Publication: Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Etzion, Ohad
Hamid, Saeed Sadiq
Asselah, Tarik
Gherlan, George Sebastian
Turcanu, Adela
Petrivna, Tsarynna
Weissfeld, Lisa
Choong, Ingrid
Hislop, Colin
Apelian, David
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Source
Publisher
Elsevier
Subject
Citation
item.page.haspartof
Source
Journal of Hepatology
item.page.ispartofseries
item.page.edition
DOI
10.1016/S0168-8278(23)00451-8
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
